JPS53136516A - Cell extracted vaccine having polysacchride capsule - Google Patents

Cell extracted vaccine having polysacchride capsule

Info

Publication number
JPS53136516A
JPS53136516A JP5262378A JP5262378A JPS53136516A JP S53136516 A JPS53136516 A JP S53136516A JP 5262378 A JP5262378 A JP 5262378A JP 5262378 A JP5262378 A JP 5262378A JP S53136516 A JPS53136516 A JP S53136516A
Authority
JP
Japan
Prior art keywords
polysacchride
capsule
cell extracted
vaccine
extracted vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5262378A
Other languages
English (en)
Inventor
Deyusuuru Danteruran Riyushian
Norumie Jieraaru
Pineru Annuumarii
Deyuran Jiyatsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of JPS53136516A publication Critical patent/JPS53136516A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP5262378A 1977-04-29 1978-05-01 Cell extracted vaccine having polysacchride capsule Pending JPS53136516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Publications (1)

Publication Number Publication Date
JPS53136516A true JPS53136516A (en) 1978-11-29

Family

ID=9190107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5262378A Pending JPS53136516A (en) 1977-04-29 1978-05-01 Cell extracted vaccine having polysacchride capsule

Country Status (10)

Country Link
JP (1) JPS53136516A (ja)
BE (1) BE866464A (ja)
CA (1) CA1103155A (ja)
CH (1) CH630806A5 (ja)
DE (1) DE2818922A1 (ja)
ES (1) ES469225A1 (ja)
FR (1) FR2388563A1 (ja)
GB (1) GB1603340A (ja)
IT (1) IT1156717B (ja)
NL (1) NL7804660A (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5495724A (en) * 1977-11-28 1979-07-28 Merck & Co Inc Streptococcus pseunomoniae vaccine
JPS5585525A (en) * 1978-12-19 1980-06-27 Fabre Sa Pierre Purified bacterial membranal proteoglycan* manufacture thereof and vaccine using it
JPH0651347U (ja) * 1992-12-21 1994-07-12 有限会社河上建築事務所 軒樋の枯葉止め

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
FR2471785A1 (fr) 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
FR2495939B1 (fr) * 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
GB8906795D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Method of preparing vaccines
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
FR2703252B1 (fr) * 1993-03-31 1996-09-06 Fernand Narbey Torossian Complexe immunomodulateur anti SIDA.
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
JP3990455B2 (ja) * 1996-02-14 2007-10-10 メルク エンド カンパニー インコーポレーテッド 多糖沈殿法
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5495724A (en) * 1977-11-28 1979-07-28 Merck & Co Inc Streptococcus pseunomoniae vaccine
JPS5585525A (en) * 1978-12-19 1980-06-27 Fabre Sa Pierre Purified bacterial membranal proteoglycan* manufacture thereof and vaccine using it
JPS6358840B2 (ja) * 1978-12-19 1988-11-17
JPH0651347U (ja) * 1992-12-21 1994-07-12 有限会社河上建築事務所 軒樋の枯葉止め

Also Published As

Publication number Publication date
DE2818922A1 (de) 1978-11-09
ES469225A1 (es) 1978-11-16
FR2388563B1 (ja) 1981-01-09
NL7804660A (nl) 1978-10-31
BE866464A (fr) 1978-10-27
GB1603340A (en) 1981-11-25
IT7849126A0 (it) 1978-04-28
CA1103155A (fr) 1981-06-16
FR2388563A1 (fr) 1978-11-24
IT1156717B (it) 1987-02-04
CH630806A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
GB2009771B (en) Vaccine
GB2005538B (en) Pharmaceutical compositsions
GB2008101B (en) Pharmaceutical preperations
JPS5414061A (en) Crusher
JPS53136516A (en) Cell extracted vaccine having polysacchride capsule
IL52695A (en) Mixing capsule
JPS5486992A (en) Lifesaving capsule
GB2001530B (en) Vaccine
JPS5492616A (en) Ubidecalenone soft capsule preparation
GB2001851B (en) Vaccine preparations
JPS53117235A (en) Disasterrproofing capsule
ZA78421B (en) New vaccine
JPS5477366A (en) Crusher
GB1552749A (en) Tablet crusher
JPS5463099A (en) Medicine
AU3454978A (en) Capsule
JPS5480408A (en) Comosite vaccine
JPS5488880A (en) Soft capsule
JPS5419257A (en) Crusher
JPS5473126A (en) Antiicancer medicine
AU4076678A (en) Nd catalystused therein
JPS5410469A (en) Crusher
JPS5445186A (en) Pressure receiving capsule
GB2009644B (en) Rotors
JPS5432610A (en) Extracting of pharmaceutically effective substance of mushrooms